A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...
The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), achieving a 36.3 percent definitive diagnosis rate while identifying six ...
Non-invasive prenatal testing (NIPT) has recently expanded to include sex chromosomal aneuploidies (SCAs) and copy number variations (CNVs), as well as the commonly screened trisomies (T21, T18, and ...
Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
To assess the detection rate of exome sequencing (ES) in fetuses diagnosed as skeletal abnormalities (SKA) with normal karyotype or chromosomal microarray analysis (CMA) results. We conducted ...
Of the final sample, 31% of patients received at least one genetic test overall, but only 11% received concordant testing and at least one other test. The current study explored the role of genetic ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Thoroughbred mares Rosalind (left) and Toppy (right) at the Baker Institute for Animal Health, Cornell University. Image credit: John Enright (Cornell University, Ithaca, NY). Studies beginning around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results